Global IBS-C Drugs Market Analysis 2015-2019 and Forecast 2020-2025

  • The global IBS-C Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of IBS-C Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Linaclotide 

    Lubiprostone 

    Osmotic Laxatives 

    Stimulant Laxatives 

    Others

    Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

    Catalent Pharmaceuticals Solutions 

    Nestle 

    Abbott Laboratories 

    Synergy Pharmaceuticals 

    Sucampo Pharmaceuticals 

    Novartis Pharma Ag 

    Astellas Pharmaceuticals 

    Ardelyx, Inc 

    Synthetic Biologics, Inc 

    Teva Pharmaceutical Industries 

    Bama-Geve, SLU 

    Ferring BV 

    Ironwood Pharmaceuticals, Inc 

    Salix Pharmaceuticals Ltd 

    Norgine B.V 

    Prometheus Laboratories Inc 

    Actavis Nordic A/S 

    Albireo Pharma Inc 

    Yuhan Corp 

    Astrazeneca Plc 

    The Menarini Group 

    Ono Pharmaceutical Co., Ltd

    Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

    Hospital Pharmacies 

    Retail Pharmacies 

    Online Pharmacies

    Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

    North America (U.S., Canada, Mexico)

    Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

    Asia-Pacific (China, India, Japan, Southeast Asia etc.)

    South America (Brazil, Argentina etc.)

    Middle East & Africa (Saudi Arabia, South Africa etc.)

     

  • With tables and figures helping analyze worldwide market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Table of Content

    1 Industry Overview

    1.1 IBS-C Drugs Industry

    Figure IBS-C Drugs Industry Chain Structure
    1.1.1 Overview
    1.1.2 Development of IBS-C Drugs

    1.2 Market Segment

    1.2.1 Upstream
    Table Upstream Segment of IBS-C Drugs
    1.2.2 Downstream
    Table Application Segment of IBS-C Drugs
    Table Global IBS-C Drugs Market 2015-2025, by Application, in USD Million

    1.3 Cost Analysis


    2 Industry Environment (PEST Analysis)

    2.1 Policy

    2.2 Economics

    2.3 Sociology

    2.4 Technology


    3 IBS-C Drugs Market by Type

    3.1 By Type

    3.1.1 Linaclotide 
    Table Major Company List of Linaclotide 
    3.1.2 Lubiprostone 
    Table Major Company List of Lubiprostone 
    3.1.3 Osmotic Laxatives 
    Table Major Company List of Osmotic Laxatives 
    3.1.4 Stimulant Laxatives 
    Table Major Company List of Stimulant Laxatives 
    3.1.5 Others
    Table Major Company List of Others

    3.2 Market Size

    Table Global IBS-C Drugs Market 2015-2019, by Type, in USD Million
    Figure Global IBS-C Drugs Market Growth 2015-2019, by Type, in USD Million
    Table Global IBS-C Drugs Market 2015-2019, by Type, in Volume
    Figure Global IBS-C Drugs Market Growth 2015-2019, by Type, in Volume

    3.3 Market Forecast

    Table Global IBS-C Drugs Market Forecast 2020-2025, by Type, in USD Million
    Table Global IBS-C Drugs Market Forecast 2020-2025, by Type, in Volume

    4 Major Companies List

    4.1 Catalent Pharmaceuticals Solutions  (Company Profile, Sales Data etc.)

    4.1.1 Catalent Pharmaceuticals Solutions  Profile
    Table Catalent Pharmaceuticals Solutions  Overview List
    4.1.2 Catalent Pharmaceuticals Solutions  Products & Services
    4.1.3 Catalent Pharmaceuticals Solutions  Business Operation Conditions
    Table Business Operation of Catalent Pharmaceuticals Solutions  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.2 Nestle  (Company Profile, Sales Data etc.)

    4.2.1 Nestle  Profile
    Table Nestle  Overview List
    4.2.2 Nestle  Products & Services
    4.2.3 Nestle  Business Operation Conditions
    Table Business Operation of Nestle  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.3 Abbott Laboratories  (Company Profile, Sales Data etc.)

    4.3.1 Abbott Laboratories  Profile
    Table Abbott Laboratories  Overview List
    4.3.2 Abbott Laboratories  Products & Services
    4.3.3 Abbott Laboratories  Business Operation Conditions
    Table Business Operation of Abbott Laboratories  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.4 Synergy Pharmaceuticals  (Company Profile, Sales Data etc.)

    4.4.1 Synergy Pharmaceuticals  Profile
    Table Synergy Pharmaceuticals  Overview List
    4.4.2 Synergy Pharmaceuticals  Products & Services
    4.4.3 Synergy Pharmaceuticals  Business Operation Conditions
    Table Business Operation of Synergy Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.5 Sucampo Pharmaceuticals  (Company Profile, Sales Data etc.)

    4.5.1 Sucampo Pharmaceuticals  Profile
    Table Sucampo Pharmaceuticals  Overview List
    4.5.2 Sucampo Pharmaceuticals  Products & Services
    4.5.3 Sucampo Pharmaceuticals  Business Operation Conditions
    Table Business Operation of Sucampo Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.6 Novartis Pharma Ag  (Company Profile, Sales Data etc.)

    4.6.1 Novartis Pharma Ag  Profile
    Table Novartis Pharma Ag  Overview List
    4.6.2 Novartis Pharma Ag  Products & Services
    4.6.3 Novartis Pharma Ag  Business Operation Conditions
    Table Business Operation of Novartis Pharma Ag  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.7 Astellas Pharmaceuticals  (Company Profile, Sales Data etc.)
    4.7.1 Astellas Pharmaceuticals  Profile
    Table Astellas Pharmaceuticals  Overview List
    4.7.2 Astellas Pharmaceuticals  Products & Services
    4.7.3 Astellas Pharmaceuticals  Business Operation Conditions
    Table Business Operation of Astellas Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.8 Ardelyx, Inc  (Company Profile, Sales Data etc.)
    4.8.1 Ardelyx, Inc  Profile
    Table Ardelyx, Inc  Overview List
    4.8.2 Ardelyx, Inc  Products & Services
    4.8.3 Ardelyx, Inc  Business Operation Conditions
    Table Business Operation of Ardelyx, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.9 Synthetic Biologics, Inc  (Company Profile, Sales Data etc.)
    4.9.1 Synthetic Biologics, Inc  Profile
    Table Synthetic Biologics, Inc  Overview List
    4.9.2 Synthetic Biologics, Inc  Products & Services
    4.9.3 Synthetic Biologics, Inc  Business Operation Conditions
    Table Business Operation of Synthetic Biologics, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.10 Teva Pharmaceutical Industries  (Company Profile, Sales Data etc.)
    4.10.1 Teva Pharmaceutical Industries  Profile
    Table Teva Pharmaceutical Industries  Overview List
    4.10.2 Teva Pharmaceutical Industries  Products & Services
    4.10.3 Teva Pharmaceutical Industries  Business Operation Conditions
    Table Business Operation of Teva Pharmaceutical Industries  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.11 Bama-Geve, SLU  (Company Profile, Sales Data etc.)
    4.11.1 Bama-Geve, SLU  Profile
    Table Bama-Geve, SLU  Overview List
    4.11.2 Bama-Geve, SLU  Products & Services
    4.11.3 Bama-Geve, SLU  Business Operation Conditions
    Table Business Operation of Bama-Geve, SLU  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.12 Ferring BV  (Company Profile, Sales Data etc.)
    4.12.1 Ferring BV  Profile
    Table Ferring BV  Overview List
    4.12.2 Ferring BV  Products & Services
    4.12.3 Ferring BV  Business Operation Conditions
    Table Business Operation of Ferring BV  (Sales Revenue, Cost, Gross Margin)
    4.13 Ironwood Pharmaceuticals, Inc  (Company Profile, Sales Data etc.)
    4.13.1 Ironwood Pharmaceuticals, Inc  Profile
    Table Ironwood Pharmaceuticals, Inc  Overview List
    4.13.2 Ironwood Pharmaceuticals, Inc  Products & Services
    4.13.3 Ironwood Pharmaceuticals, Inc  Business Operation Conditions
    Table Business Operation of Ironwood Pharmaceuticals, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.14 Salix Pharmaceuticals Ltd  (Company Profile, Sales Data etc.)
    4.14.1 Salix Pharmaceuticals Ltd  Profile
    Table Salix Pharmaceuticals Ltd  Overview List
    4.14.2 Salix Pharmaceuticals Ltd  Products & Services
    4.14.3 Salix Pharmaceuticals Ltd  Business Operation Conditions
    Table Business Operation of Salix Pharmaceuticals Ltd  (Sales Revenue, Cost, Gross Margin)
    4.15 Norgine B.V  (Company Profile, Sales Data etc.)
    4.15.1 Norgine B.V  Profile
    Table Norgine B.V  Overview List
    4.15.2 Norgine B.V  Products & Services
    4.15.3 Norgine B.V  Business Operation Conditions
    Table Business Operation of Norgine B.V  (Sales Revenue, Cost, Gross Margin)
    4.16 Prometheus Laboratories Inc  (Company Profile, Sales Data etc.)
    4.16.1 Prometheus Laboratories Inc  Profile
    Table Prometheus Laboratories Inc  Overview List
    4.16.2 Prometheus Laboratories Inc  Products & Services
    4.16.3 Prometheus Laboratories Inc  Business Operation Conditions
    Table Business Operation of Prometheus Laboratories Inc  (Sales Revenue, Cost, Gross Margin)
    4.17 Actavis Nordic A/S  (Company Profile, Sales Data etc.)
    4.17.1 Actavis Nordic A/S  Profile
    Table Actavis Nordic A/S  Overview List
    4.17.2 Actavis Nordic A/S  Products & Services
    4.17.3 Actavis Nordic A/S  Business Operation Conditions
    Table Business Operation of Actavis Nordic A/S  (Sales Revenue, Cost, Gross Margin)
    4.18 Albireo Pharma Inc  (Company Profile, Sales Data etc.)
    4.18.1 Albireo Pharma Inc  Profile
    Table Albireo Pharma Inc  Overview List
    4.18.2 Albireo Pharma Inc  Products & Services
    4.18.3 Albireo Pharma Inc  Business Operation Conditions
    Table Business Operation of Albireo Pharma Inc  (Sales Revenue, Cost, Gross Margin)
    4.19 Yuhan Corp  (Company Profile, Sales Data etc.)
    4.19.1 Yuhan Corp  Profile
    Table Yuhan Corp  Overview List
    4.19.2 Yuhan Corp  Products & Services
    4.19.3 Yuhan Corp  Business Operation Conditions
    Table Business Operation of Yuhan Corp  (Sales Revenue, Cost, Gross Margin)
    4.20 Astrazeneca Plc  (Company Profile, Sales Data etc.)
    4.20.1 Astrazeneca Plc  Profile
    Table Astrazeneca Plc  Overview List
    4.20.2 Astrazeneca Plc  Products & Services
    4.20.3 Astrazeneca Plc  Business Operation Conditions
    Table Business Operation of Astrazeneca Plc  (Sales Revenue, Cost, Gross Margin)
    4.21 The Menarini Group  (Company Profile, Sales Data etc.)
    4.21.1 The Menarini Group  Profile
    Table The Menarini Group  Overview List
    4.21.2 The Menarini Group  Products & Services
    4.21.3 The Menarini Group  Business Operation Conditions
    Table Business Operation of The Menarini Group  (Sales Revenue, Cost, Gross Margin)
    4.22 Ono Pharmaceutical Co., Ltd (Company Profile, Sales Data etc.)
    4.22.1 Ono Pharmaceutical Co., Ltd Profile
    Table Ono Pharmaceutical Co., Ltd Overview List
    4.22.2 Ono Pharmaceutical Co., Ltd Products & Services
    4.22.3 Ono Pharmaceutical Co., Ltd Business Operation Conditions
    Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)

    5 Market Competition

    5.1 Company Competition

    Table Global IBS-C Drugs Sales Revenue 2015-2019, by Company, in USD Million
    Table Global IBS-C Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
    Figure Global IBS-C Drugs Sales Revenue Share in 2019, by Company, in USD Million
    Table Global IBS-C Drugs Sales Volume 2015-2019, by Company, in Volume
    Table Global IBS-C Drugs Sales Volume Share 2015-2019, by Company, in Volume
    Figure Global IBS-C Drugs Sales Volume Share in 2019, by Company, in Volume

    5.2 Regional Market by Company

    Figure North America IBS-C Drugs Market Concentration, in 2019
    Figure Europe IBS-C Drugs Market Market Concentration, in 2019
    Figure Asia-Pacific IBS-C Drugs MMarket Concentration, in 2019
    Figure South America IBS-C Drugs Market Concentration, in 2019
    Figure Middle East & Africa IBS-C Drugs Market Concentration, in 2019

    6 Demand by End Market

    6.1 Demand Situation

    6.1.1 Demand in Hospital Pharmacies 
    Figure IBS-C Drugs Demand in Hospital Pharmacies , 2015-2019, in USD Million
    Figure IBS-C Drugs Demand in Hospital Pharmacies , 2015-2019, in Volume
    6.1.2 Demand in Retail Pharmacies 
    Figure IBS-C Drugs Demand in Retail Pharmacies , 2015-2019, in USD Million
    Figure IBS-C Drugs Demand in Retail Pharmacies , 2015-2019, in Volume
    6.1.3 Demand in Online Pharmacies
    Figure IBS-C Drugs Demand in Online Pharmacies, 2015-2019, in USD Million
    Figure IBS-C Drugs Demand in Online Pharmacies, 2015-2019, in Volume

    6.2 Regional Demand Comparison

    Table Regional Demand Comparison List
    Table Major Application in Different Regions

    6.3 Demand Forecast

    Table IBS-C Drugs Demand Forecast 2020-2025, by Application, in USD Million
    Figure IBS-C Drugs Market Growth 2020-2025, by Application, in USD Million
    Figure IBS-C Drugs Market Share in 2025, by Application, in USD Million
    Table IBS-C Drugs Demand Forecast 2020-2025, by Application, in Volume
    Table IBS-C Drugs Market Growth 2020-2025, by Application, in Volume
    Table IBS-C Drugs Market Share in 2025, by Application, in Volume

    7 Region Operation

    7.1 Regional Production

    Table IBS-C Drugs Production 2015-2019, by Region, in USD Million
    Table IBS-C Drugs Production 2015-2019, by Region, in Volume

    7.2 Regional Market

    Table Global IBS-C Drugs Market 2015-2019, by Region, in USD Million
    Table Global IBS-C Drugs Market Share 2015-2019, by Region, in USD Million
    Table Global IBS-C Drugs Market 2015-2019, by Region, in Volume
    Table Global IBS-C Drugs Market Share 2015-2019, by Region, in Volume

    7.3 by Region

    7.3.1 North America
    7.3.1.1 Overview
    Figure North America IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
    Figure North America IBS-C Drugs Market Size and Growth 2015-2019, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
    Table North America IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
    Table North America IBS-C Drugs Market Size 2015-2019, by Country, in Volume
    7.3.2 Europe
    7.3.2.1 Overview
    Figure Europe IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
    Figure Europe IBS-C Drugs Market Size and Growth 2015-2019, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
    Table Europe IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
    Table Europe IBS-C Drugs Market Size 2015-2019, by Country, in Volume
    7.3.3 Asia-Pacific
    7.3.3.1 Overview
    Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
    Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2015-2019, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
    Table Asia-Pacific IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
    Table Asia-Pacific IBS-C Drugs Market Size 2015-2019, by Country, in Volume
    7.3.4 South America
    7.3.4.1 Overview
    Figure South America IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
    Figure South America IBS-C Drugs Market Size and Growth 2015-2019, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
    Table South America IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
    Table South America IBS-C Drugs Market Size 2015-2019, by Country, in Volume
    7.3.5 Middle East & Africa
    7.3.5.1 Overview
    Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
    Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2015-2019, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
    Table Middle East & Africa IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
    Table Middle East & Africa IBS-C Drugs Market Size 2015-2019, by Country, in Volume

    7.4 Regional Import & Export

    7.5 Regional Forecast

    Table IBS-C Drugs Market Forecast 2020-2025, by Region, in USD Million
    Table IBS-C Drugs Market Forecast 2020-2025, by Region, in Volume

    8 Marketing & Price

    8.1 Price and Margin

    8.1.1 Price Trends
    8.1.2 Factors of Price Change
    Table Price Factors List
    8.1.3 Manufacturers Gross Margin Analysis

    8.2 Marketing Channel

    Figure Marketing Channels Overview

    9 Research Conclusion

     

  • The Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
Licensing options
2980
USD

Need assistance ?

Research objectives

Where will all these developments take the industry in the long

To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

What are the future opportunities in the market?

To understand the structure of Market by identifying its various subsegments.

What are the major driving forces expected to impact the development of the market market across different regions?

To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

To project the consumption of market submarkets, with respect to key regions.

Who are the major driving forces expected to decide the fate of the industry worldwide.

To strategically profile the key players and comprehensively analyze their growth strategies.

What are the key barriers and threats believed to hinder the development of the industry?

To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

Who are the prominent market players making a mark in the market with their winning strategies?

To share detailed information about the key factors influencing the growth of the market

What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Our Clients